Regulation of miR-34b/c-targeted gene expression program by SUMOylation

被引:20
|
作者
Li, Yi-Jia [1 ]
Du, Li [1 ]
Aldana-Masangkay, Grace [1 ]
Wang, Xiuli [2 ]
Urak, Ryan [2 ]
Forman, Stephen J. [2 ]
Rosen, Steven T. [2 ]
Chen, Yuan [1 ]
机构
[1] Beckman Res Inst City Hope, Dept Mol Med, Duarte, CA 91010 USA
[2] Beckman Res Inst City Hope, Dept Hematol & Hematopoiet Cell Transplantat, Duarte, CA 91010 USA
关键词
FORKHEAD TRANSCRIPTION FACTOR; SUMO-BINDING MOTIF; MULTIPLE-MYELOMA; CELL-PROLIFERATION; BREAST-CANCER; IN-VIVO; MYC; TUMORIGENESIS; TARGET; LYMPHOMA;
D O I
10.1093/nar/gky484
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The miR-34 family of microRNAs suppresses the expression of proteins involved in pluripotency and oncogenesis. miR-34 expression is frequently reduced in cancers; however, the regulation of their expression is not well understood. We used genome-wide miRNA profiling and mechanistic analysis to show that SUMOylation regulates miR-34b/c expression, which impacts the expression of c-Myc and other tested miR-34 targets. We used site directed mutagenesis and other methods to show that protein kinase B (also known as Akt) phosphorylation of FOXO3a plays an important role in SUMOylation-dependent expression of miR-34b/c. This study reveals how the miR-34-targeted gene expression program is regulated by SUMOylation and shows that SUMOylation need not regulate target proteins through direct modification, but instead can act through the expression of their targeting miRNAs.
引用
收藏
页码:7108 / 7123
页数:16
相关论文
共 50 条
  • [21] Epigenetic inactivation of miR-34b/c in addition to miR-34a and DAPK1 in chronic lymphocytic leukemia
    Qian, Lu
    Kwong, Yok Lam
    Wong, Kit Fai
    Kho, Chi Shan Bonnie
    Jin, Dong Yan
    Tse, Eric
    Rosen, Anders
    Chim, Chor Sang
    LEUKEMIA & LYMPHOMA, 2013, 54 : 16 - 16
  • [22] A polymorphism in mir-34b/c as a potential biomarker for early onset of hereditary retinoblastoma
    Carvalho, Ivna N. S. R.
    Reis, Adriana H. O.
    dos Santos, Anna C. E.
    Vargas, Fernando R.
    CANCER BIOMARKERS, 2017, 18 (03) : 313 - 317
  • [23] Epigenetic inactivation of mir-34b/c in addition to mir-34a and DAPK1 in chronic lymphocytic leukemia
    Wang, Lu Qian
    Kwong, Yok Lam
    Wong, Kit Fai
    Kho, Chi Shan Bonnie
    Jin, Dong Yan
    Tse, Eric
    Rosen, Anders
    Chim, Chor Sang
    JOURNAL OF TRANSLATIONAL MEDICINE, 2014, 12
  • [24] Prognostic impact of miR-34b/c DNA methylation, gene expression, and promoter polymorphism in HPV-negative oral squamous cell carcinomas
    Gordana Supic
    Debora Stefik
    Nemanja Ivkovic
    Ahmad Sami
    Katarina Zeljic
    Sasa Jovic
    Ruzica Kozomara
    Danilo Vojvodic
    Srboljub Stosic
    Scientific Reports, 12
  • [25] Prognostic impact of miR-34b/c DNA methylation, gene expression, and promoter polymorphism in HPV-negative oral squamous cell carcinomas
    Supic, Gordana
    Stefik, Debora
    Ivkovic, Nemanja
    Sami, Ahmad
    Zeljic, Katarina
    Jovic, Sasa
    Kozomara, Ruzica
    Vojvodic, Danilo
    Stosic, Srboljub
    SCIENTIFIC REPORTS, 2022, 12 (01)
  • [26] miR-34b—a novel plasma marker for Huntington disease?
    Vanisha Parekh
    Nature Reviews Neurology, 2011, 7 (6) : 304 - 304
  • [27] Methylation of miR-34a, miR-34b/c, miR-124-1 and miR-203 in Ph-negative myeloproliferative neoplasms
    Chor Sang Chim
    Thomas S Wan
    Kwan Yeung Wong
    Tsz Kin Fung
    Hans G Drexler
    Kit Fai Wong
    Journal of Translational Medicine, 9
  • [28] Methylation of miR-34a, miR-34b/c, miR-124-1 and miR-203 in Ph-negative myeloproliferative neoplasms
    Chim, Chor Sang
    Wan, Thomas S.
    Wong, Kwan Yeung
    Fung, Tsz Kin
    Drexler, Hans G.
    Wong, Kit Fai
    JOURNAL OF TRANSLATIONAL MEDICINE, 2011, 9
  • [29] Effect of miR-34b/c rs4938723 T > C on pediatric glioma susceptibility
    Jia, Xingyu
    Chen, Wenchao
    Chen, Wei
    Liao, Yuxiang
    Zhou, Jingying
    Yuan, Li
    Lin, Huiran
    Bian, Jun
    PRECISION MEDICAL SCIENCES, 2022, 11 (02): : 82 - 86
  • [30] Detection of miR-34a and miR-34b/c in stool sample as potential screening biomarkers for noninvasive diagnosis of colorectal cancer
    Xuan-di Wu
    Yong-Chun Song
    Pei-Long Cao
    Hao Zhang
    Qi Guo
    Rong Yan
    Dong-mei Diao
    Yao Cheng
    Cheng-Xue Dang
    Medical Oncology, 2014, 31